One study has shown that overexpression of MRP1 (which is frequently observed in multi-drug resistant cancer cells) causes resistance to an IL-4–PE fragment immunotoxin, though overexpression of MRP2-5 or the P-glycoprotein transporter had no effect. This evidence concerns the gene IL4 and cancer.